NasdaqGS:NOVT - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2025	1,080	106	122	150	3
12/31/2024	981	76	N/A	160	3
3/29/2024	893	69	120	143	N/A
12/31/2023	882	73	100	120	N/A
9/29/2023	888	76	104	122	N/A
6/30/2023	890	77	77	92	N/A
3/31/2023	876	73	73	90	N/A
12/31/2022	861	74	70	91	N/A
9/30/2022	841	73	57	79	N/A
7/1/2022	796	64	53	78	N/A
4/1/2022	748	58	58	83	N/A
12/31/2021	707	50	72	95	N/A
10/1/2021	655	49	92	112	N/A
7/2/2021	621	44	124	141	N/A
4/2/2021	598	44	132	146	N/A
12/31/2020	591	45	127	140	N/A
10/2/2020	603	41	117	129	N/A
7/3/2020	614	42	82	94	N/A
4/3/2020	624	40	62	76	N/A
12/31/2019	626	41	53	63	N/A
9/27/2019	623	43	38	50	N/A
6/28/2019	629	56	56	70	N/A
3/29/2019	625	57	59	75	N/A
12/31/2018	614	51	73	90	N/A
9/28/2018	605	39	74	90	N/A
6/29/2018	591	18	61	74	N/A
3/30/2018	559	12	61	71	N/A
12/31/2017	521	40	N/A	63	N/A
9/29/2017	473	48	N/A	54	N/A
6/30/2017	425	55	N/A	54	N/A
3/31/2017	403	54	N/A	52	N/A
12/31/2016	385	22	N/A	48	N/A
9/30/2016	376	20	N/A	43	N/A
7/1/2016	371	19	N/A	43	N/A
4/1/2016	369	34	N/A	36	N/A
12/31/2015	374	36	N/A	33	N/A
10/2/2015	377	1	N/A	34	N/A
7/3/2015	380	0	N/A	37	N/A
4/3/2015	380	-16	N/A	47	N/A
12/31/2014	365	-17	N/A	42	N/A
9/26/2014	353	16	N/A	48	N/A
6/27/2014	338	13	N/A	52	N/A
3/28/2014	321	11	N/A	46	N/A
12/31/2013	317	10	N/A	49	N/A
9/27/2013	301	20	N/A	41	N/A
6/28/2013	291	20	N/A	27	N/A

アナリストによる今後の成長予測

収入対貯蓄率: NOVTの予測収益成長率 (年間25.5% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: NOVTの収益 ( 25.5% ) はUS市場 ( 14.8% ) よりも速いペースで成長すると予測されています。

高成長収益: NOVTの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: NOVTの収益 ( 10.8% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: NOVTの収益 ( 10.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: NOVTの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Novanta 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2024

Price target increased by 11% to US$173

Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024

Price target decreased by 8.5% to US$156

Novanta Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Full Year 2023

Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2023

Recent updates

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Novanta Inc. to Report Q1, 2024 Results on May 07, 2024

Price target increased by 11% to US$173

Novanta Inc., Annual General Meeting, May 08, 2024

CEO & Chairman of the Board exercised options and sold US$886k worth of stock

Novanta Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Novanta Inc. to Report Q4, 2023 Results on Feb 28, 2024

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

CEO & Chairman of the Board notifies of intention to sell stock

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Price target decreased by 8.5% to US$156

Investor sentiment improves as stock rises 18%

Novanta Inc. Provides Revenue Guidance for the Fourth Quarter of 2023 and Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta Inc. to Report Q3, 2023 Results on Nov 07, 2023

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Chief Financial Officer notifies of intention to sell stock

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target increased by 7.6% to US$171

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Novanta Inc. to Report Q2, 2023 Results on Aug 08, 2023

CEO & Chairman of the Board notifies of intention to sell stock

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Price target increased by 10% to US$159

Full year 2022 earnings: EPS misses analyst expectations

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

CEO & Chairman of the Board exercised options to buy US$459k worth of stock.

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Chief Human Resources Officer notifies of intention to sell stock

Novanta Inc. to Report Q4, 2022 Results on Mar 01, 2023

Chief Financial Officer notifies of intention to sell stock

Chief Financial Officer notifies of intention to sell stock

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Chief Human Resources Officer exercised options and sold US$1.0m worth of stock

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Chief Financial Officer notifies of intention to sell stock

Chief Financial Officer notifies of intention to sell stock

High number of new directors

Chief Financial Officer notifies of intention to sell stock

Price target decreased to US$138

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Novanta Inc. Provides Financial Guidance for the Fourth Quarter and Full Year 2022

Chief Financial Officer notifies of intention to sell stock

Is Novanta (NASDAQ:NOVT) Using Too Much Debt?

Independent Director notifies of intention to sell stock

Novan, Inc., Epi Health and MC2 Therapeutics Present New Data in Multiple Posters Highlighting Wynzora’s Unique Pad Technology At the 42Nd Annual Fall Clinical Dermatology Conference

Novanta Inc. to Report Q3, 2022 Results on Nov 08, 2022

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

With EPS Growth And More, Novanta (NASDAQ:NOVT) Makes An Interesting Case

Novanta Inc. (NASDAQ:NOVT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2022

Novanta Non-GAAP EPS of $0.78 beats by $0.06, revenue of $215.34M beats by $6.27M, raises FY guidance

Novanta (NASDAQ:NOVT) Could Easily Take On More Debt